FDA Drug Application (081213) for ESTROPIPATE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number081213
Product Number001
FormTABLET;ORAL
Dosage0.75MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameESTROPIPATE
Active IngredientESTROPIPATE

Active IngredientCount
List of drugs with Active Ingredient ESTROPIPATE7


Back to FDA Applications sponsored by WATSON LABS